Patents over the last 10 years

  1. Routier, S. ; Suzenet, F. ; Chalon, S. ; Buron, F. ; Vercouillie, J. ; Melki, R. ; Boiaryna, L. ; Guilloteau, D. ; Pieri, L.
    Compounds for using in imagery and particularly for the diagnosis of neuro​degenerative diseases
  2. Patent N° Kind Date Application N° Date
    FR 3056592 A1 30 mar. 2018 FR 2016-59033 26 sep. 2016
    WO 2018055316 A1 29 mar. 2018 WO 2017-FR52592 26 sep. 2017

        Priority :
                      FR 2016-59033 A 26 sep. 2016
                      FR 2017-52001 A 10 mar. 2017
        ref. chem. Abstract : 168:387407

  3. Routier, S. ; Bénédetti, H. ; Buron, F. ; Hiebel, M.-A. ; Saurat, T. ; Guillaumet, G.
    Preparation of trisubstituted pyrido[2,​3-​d]​pyrimidines as inhibitors of PI3K and mTOR kinases
  4. Patent N° Kind Date Application N° Date
    FR 2994572 A1 21 Feb 2014 FR 2012-57856 17 Aug 2012
    FR 2994572 B1 17 Apr 2015
    CA 2881110 A1 20 Feb 2014 CA 2013-2881110 16 Aug 2013
    WO 2014027081 A1 20 Feb 2014 WO 2013-EP67129 16 Aug 2013
    AU 2013304046 A1 26 Feb 2015 AU 2013-304046 16 Aug 2013
    KR 2015046155 A 29 Apr 2015 KR 2015-7006805 16 Aug 2013
    CN 104718203 A 17Jun 2015 CN 2013-80049835 16 Aug 2013
    EP 2885297 A1 24 Jun 2015 EP 2013-750072 16 Aug 2013
    US 20150203489 A1 23 Jul 2015 US 2015-14421402 12 Feb 2015

        Priority application :
                      FR 2012-57856 A 17 Aug. 2012
                      WO 2013-EP67129 W 16 Aug 2013
        ref. chem. Abstract : 160:370183

  5. Routier, S. ; Suzenet, F. ; Pin, F. ; Chalon, S. ; Vercouillie, J. ; Guilloteau, D.
    Preparation of 1,4-disubstituted 1,2,3-triazoles, especially triazolyltropanes and triazolylquinuclidines, as α7 nicotinic receptor modulators useful as diagnostic and thera
  6. Patent N° Kind Date Application N° Date
    FR 2974365 A1 26 oct. 2012 FR 2011-53420 20 apr. 2011
    CA 2833648 A1 26 oct. 2012 CA 2012-2833648 20 apr. 2012
    WO 2012143526 A1 26 oct. 2012 WO 2012-EP57309 20 apr. 2012
    AU 2012245118 A1 7 nov. 2013 AU 2012-245118 20 apr. 2012
    EP 2699570 A1 26 feb. 2014 EP 2012-715117 20 apr. 2012
    CN 103649084 A 19 mar. 2014 CN 2012-80029991 20 apr. 2012
    JP 2014515754 T 3 jul. 2014 JP 2014-505656 20 apr. 2012
    JP 5969004 B2 10 Aug. 2016
    US 20140030191 A1 30 jan. 2014 US 2013-14112864 18 oct. 2013

        Priority :
                      FR 2011-53420 A, 20 Apr 2011
                      WO 2012-EP57309 W, 20 Apr 2012
        ref. chem. Abstract : 157:663263

  7. Routier, S. ; Guillaumet, G. ; Tikad, A. ; Dehbi, O.
    Preparation of pyrido[3,2-d]pyrimidine derivatives as inhibitors of CDK1, DYRK1A, CDK5 and/or GSK3 kinases
  8. Patent N° Kind Date Application N° Date
    FR 2959510 A1 03 nov. 2011 FR 2010-53277 28 apr. 2010
    FR 2959510 B1 26 apr. 2013
    WO 2011135259 A1 3 nov. 2011 WO 2011-FR50959 28 apr. 2011
    US 20130109693 A1 2 may. 2013 US 2012-695001 20 dec. 2012

        Priority application :
                      FR2010-53277 A 28 apr. 2010
                      WO 2011-FR50959 W 28 apr. 2011
        ref. chem. Abstract : 155:637809

  9. Routier, S. ; Guillaumet, G. ; Meyjer, L. ; Chiurato, M. ; Boulahjar, R.
    Preparation of 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bH)-one derivatives as inhibitors of CDK1, CDK5 and/or GSK3 kinases
  10. Patent N° Kind Date Application N° Date
    FR 2943057 A1 17 Sep. 2010 FR 2009-51551 12 Mar. 2009
    FR 2943057 B1 23 jun. 2011
    CA 2755157 A1 16 sep. 2010 CA 2010-2755157 11 mar. 2010
    WO 2010103240 A1 16 Sep. 2010 WO 2010-FR50416 11 Mar. 2010
    EP 2406261 A1 18 jan. 2012 EP 2010-715918 11 mar. 2010
    EP 2406261 B1 9 Jan 2013
    JP 2012520272 T 06 sep. 2012 JP 2011-553496 11 mar. 2010
    US 20120095022 A1 19 apr. 2012 US 2011-256017 27 dec. 2011

        Priority application :
                      FR 2009-51551 A 12 mar. 2009
                      WO 2010-FR50416 W 11 mar. 2010
        ref. chem. Abstract : 153:431389